QScreen AI Inc. is a technology company specializing in artificial intelligence-powered solutions for workplace health and safety and the healthcare industry. Operating in two primary segments—Workplace Health and Safety, and Healthcare—it develops innovative tools such as infectious disease symptom screening solutions to detect potential cases requiring confirmatory tests like rapid COVID assessments. The company also offers impairment detection screening scanners for alcohol and cannabis, mental health screening stations, and Mobile Wellbeing, a telemedicine platform for remote patient monitoring, chronic disease management, and personalized treatment plans using real-time medical data. QScreen AI Inc. incorporates quantum-inspired and advanced computational techniques with classical machine learning to enhance detection accuracy, speed, and scalability in complex environments. It maintains a strategic alliance with Pacific Mechatronics Pvt. Ltd. to expand AI health screening in defense sectors. Formerly Predictmedix AI Inc., it rebranded in January 2026 and is headquartered in Toronto, Canada, led by CEO Sheldon Kales. QScreen AI Inc. plays a key role in advancing AI-driven health screening and decision-intelligence platforms for industrial, clinical, and remote settings.